Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
1.570
-0.050 (-3.09%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Galmed Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
452134666
Upgrade
Market Cap Growth
163.69%163.69%-85.53%-72.40%-31.12%-45.72%
Upgrade
Enterprise Value
-12-12-11-748
Upgrade
Last Close Price
1.573.195.4690.00327.60559.80
Upgrade
PB Ratio
0.160.290.130.941.501.50
Upgrade
P/TBV Ratio
0.220.290.130.941.501.50
Upgrade
Debt / Equity Ratio
--0.000.020.010.01
Upgrade
Quick Ratio
7.157.154.664.515.946.36
Upgrade
Current Ratio
7.427.424.814.766.136.47
Upgrade
Return on Equity (ROE)
-49.77%-49.77%-50.63%-81.36%-86.98%-50.47%
Upgrade
Return on Assets (ROA)
-22.34%-22.34%-28.22%-41.50%-46.19%-29.16%
Upgrade
Return on Capital (ROIC)
-25.95%-25.95%-33.98%-49.50%-54.44%-32.90%
Upgrade
Earnings Yield
-212.04%-156.37%-379.13%-141.78%-71.12%-43.41%
Upgrade
FCF Yield
-165.86%-122.31%-336.62%-146.85%-72.07%-39.73%
Upgrade
Buyback Yield / Dilution
-303.31%-303.31%-65.23%-2.22%-15.59%-0.79%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q